MASTL and cancer: Interestingly, we and other groups showed MASTL upregulation in multiple types of cancer, in association with aggressive clinicopathological features (Wang et al., 2014a; Vera et al., 2015; Sun et al., 2017; Tian et al., 2017; Zhuge et al., 2017; Alvarez-Fernandez et al., 2018; Rogers et al., 2018; Uppada et al., 2018; Fatima et al., 2021).